Loading
Everything OnCo dates to 1965: 12 entries, 7 landmarks, 2 journals founded, 1 approval and 1 company founded. Each line links to the record it was read from, so the year is a view of the corpus rather than a second copy of it.
12 dated entries in OnCo fall in 1965: 7 landmarks, 2 journals founded, 1 approval, 1 company founded and 1 technology.
Of those, 12 to the year only. Most of the corpus dates a fact to the year, because that is what the source it was read from gives; regulatory events and the readout calendar are the parts that carry a full date.
Everything on this page is generated from the other records. It holds no fact of its own, and it changes when they do.
The approvals rows on treatment records: region, year and indication.
Hodgkin lymphoma, testicular cancer, Kaposi sarcoma, choriocarcinoma, breast cancer and others
The history entries editors wrote on cancer records: the dated turning points of each disease.
Childhood cancers (all types). Multi-drug regimens at the National Cancer Institute and St Jude turned acute lymphoblastic leukaemia from uniformly fatal to curable.
Rosai-Dorfman-Destombes disease
Extrahepatic cholangiocarcinoma (perihilar and distal)
Biliary tract cancer (cholangiocarcinoma). Distinct clinicopathologic entity at the hepatic duct confluence.
Biliary tract cancer (all types)
Gastric & gastro-oesophageal junction cancer
Nasal cavity and paranasal sinus cancers (including esthesioneuroblastoma). Occupational epidemiology in the UK furniture industry (Acheson).
The since year on technology records: first use in humans or first approval, as the record states it.
First use in humans or first approval, as the technology record states it.
The founded year on company records.
Holbæk
The founded year on journal records.
Elsevier
Springer